Literature DB >> 21308683

Hypermethylation of tumor-related genes in Tunisian patients with gastric carcinoma: clinical and biological significance.

Dorra Ben Ayed-Guerfali1, Khemais Benhaj, Abdelmajid Khabir, Mohamed Abid, Mohamed Issam Bayrouti, Tahia Sellami-Boudawara, Ali Gargouri, Raja Mokdad-Gargouri.   

Abstract

BACKGROUND: Promoter hypermethylation is an alternative mechanism of gene silencing in cancers including gastric carcinoma (GC). Its affects genes with crucial functions as tumor suppressor.
METHODS: DNA methylation in the promoter of P16INK4a, DAPK, retinoic acid receptor β (RARβ2), RASSF1A, and CDH1 genes was investigated in 79 Tunisian patients with GC using methylation-specific PCR.
RESULTS: The methylation frequencies vary from 31.6% for P16INK4a to 65.8% for RARβ2. Hypermethylation of DAPK and CDH1 was associated with tumor grade and age (P = 0.04 and 0.034) respectively, while hypermethylation of RASSF1A correlated with TNM stage (P = 0.027). The distribution of the methylated DNA at P16INK4a, DAPK, and CDH1 promoters were different in the intestinal and diffuse histotypes of GC according to TNM. Moreover, the survival rate of patients with P16INK4a methylated status was shorter than that of patients with the unmethylated status (P log rank = 0.009). On the other hand, the hypermethylation of RARβ2 correlated with COX-2 expression (P = 0.001).
CONCLUSION: We showed that methylation of P16INK4a is predictive of poor prognosis and could be a useful marker. Moreover, the association between RARβ2 methylation and COX-2 expression suggests a functional link between these two proteins in gastric carcinogenesis.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21308683     DOI: 10.1002/jso.21875

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

1.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

2.  A novel all-trans retinoic acid derivative inhibits proliferation and induces differentiation of human gastric carcinoma xenografts via up-regulating retinoic acid receptor β.

Authors:  Jing Ju; Nan Wang; Xinqun Wang; Feihu Chen
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

3.  Prognostic significance of aberrant gene methylation in gastric cancer.

Authors:  Jing Shi; Guanjun Zhang; Demao Yao; Wei Liu; Na Wang; Meiju Ji; Nongyue He; Bingyin Shi; Peng Hou
Journal:  Am J Cancer Res       Date:  2011-11-21       Impact factor: 6.166

Review 4.  Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.

Authors:  Jun Nakamura; Tomokazu Tanaka; Yoshihiko Kitajima; Hirokazu Noshiro; Kohji Miyazaki
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

5.  Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis.

Authors:  Fausto Petrelli; Rosa Berenato; Luca Turati; Alessia Mennitto; Francesca Steccanella; Marta Caporale; Pierpaolo Dallera; Filippo de Braud; Ezio Pezzica; Maria Di Bartolomeo; Giovanni Sgroi; Vincenzo Mazzaferro; Filippo Pietrantonio; Sandro Barni
Journal:  J Gastrointest Oncol       Date:  2017-02

Review 6.  The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis.

Authors:  Xiang-Bin Xing; Wei-Bin Cai; Liang Luo; Long-Shan Liu; Hui-Juan Shi; Min-Hu Chen
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

Review 7.  The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review.

Authors:  Wei Zeng; Jinfeng Zhu; Li Shan; Zhigang Han; Patiguli Aerxiding; Amina Quhai; Fanye Zeng; Ziwei Wang; Huiwu Li
Journal:  Drug Des Devel Ther       Date:  2015-04-13       Impact factor: 4.162

Review 8.  Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis.

Authors:  Wenzhuo Jia; Tao Yu; Xianglong Cao; Qi An; Hua Yang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

9.  Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer.

Authors:  Xie Zhang; Xuesong Zhang; Beilei Sun; Hongna Lu; Danping Wang; Xiaogang Yuan; Zhigang Huang
Journal:  Oncol Lett       Date:  2014-08-04       Impact factor: 2.967

10.  Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach.

Authors:  Rita Kupcinskaite-Noreikiene; Rasa Ugenskiene; Alius Noreika; Viktoras Rudzianskas; Jurgita Gedminaite; Jurgita Skieceviciene; Elona Juozaityte
Journal:  BMC Cancer       Date:  2016-01-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.